Antigen-Dependent IL-12 Signaling in CAR T Cells Promotes Regional to Systemic Disease Targeting

Scientists described CAR T cells targeting tumor-associated glycoprotein-72, utilizing the CD28 transmembrane domain upstream of the 4-1BB co-stimulatory domain as a driver of potent anti-tumor activity and interferon gamma secretion.